165 related articles for article (PubMed ID: 16145474)
1. A polymorphism of the osteopontin gene is related to urinary calcium stones.
Gao B; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Oct; 174(4 Pt 1):1472-6. PubMed ID: 16145474
[TBL] [Abstract][Full Text] [Related]
2. Analysis of osteopontin DNA in patients with urolithiasis.
Yamate T; Tsuji H; Amasaki N; Iguchi M; Kurita T; Kohri K
Urol Res; 2000 Jun; 28(3):159-66. PubMed ID: 10929424
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones.
Chen WC; Wu HC; Chen HY; Wu MC; Hsu CD; Tsai FJ
Urol Res; 2001 Oct; 29(5):321-4. PubMed ID: 11762793
[TBL] [Abstract][Full Text] [Related]
4. Detection of osteopontin as matrix protein in calcium-containing urinary stones.
Yamate T; Umekawa T; Iguchi M; Kurita T; Kohri K
Hinyokika Kiyo; 1997 Sep; 43(9):623-7. PubMed ID: 9365840
[TBL] [Abstract][Full Text] [Related]
5. Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone.
Tawada T; Fujita K; Sakakura T; Shibutani T; Nagata T; Iguchi M; Kohri K
Urol Res; 1999 Aug; 27(4):238-42. PubMed ID: 10460892
[TBL] [Abstract][Full Text] [Related]
6. Quantification of osteopontin in the urine of healthy and stone-forming men.
Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the development of calcium oxalate stones and polymorphisms in the fibronectin gene in the Uighur population of the Xinjiang region of China.
Murat M; Aekeper A; Yuan LY; Alim T; Du GJ; Abdusamat A; Wu GW; Aniwer Y
Genet Mol Res; 2015 Oct; 14(4):13728-34. PubMed ID: 26535688
[TBL] [Abstract][Full Text] [Related]
8. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism.
Xu G; Sun W; He D; Wang L; Zheng W; Nie H; Ni L; Zhang D; Li N; Zhang J
J Rheumatol; 2005 Mar; 32(3):410-6. PubMed ID: 15742430
[TBL] [Abstract][Full Text] [Related]
10. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
Tugcu V; Simsek A; Tarhan T; Atalar F; Bitkin A; Tasci AI; Kural AR; Altug T
Ren Fail; 2013 Jul; 35(6):825-9. PubMed ID: 23692545
[TBL] [Abstract][Full Text] [Related]
11. Association of E-cadherin gene 3'-UTR C/T polymorphism with calcium oxalate stone disease.
Tsai FJ; Wu HC; Chen HY; Lu HF; Hsu CD; Chen WC
Urol Int; 2003; 70(4):278-81. PubMed ID: 12740491
[TBL] [Abstract][Full Text] [Related]
12. Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis.
Tsai FJ; Lin CC; Lu HF; Chen HY; Chen WC
Urology; 2002 Mar; 59(3):458-61. PubMed ID: 11880102
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor gene Alw I, Fok I, Apa I, and Taq I polymorphisms in patients with urinary stone.
Seo IY; Kang IH; Chae SC; Park SC; Lee YJ; Yang YS; Ryu SB; Rim JS
Urology; 2010 Apr; 75(4):923-7. PubMed ID: 20018354
[TBL] [Abstract][Full Text] [Related]
14. Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
Nishio S; Hatanaka M; Takeda H; Iseda T; Iwata H; Yokoyama M
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S394-6. PubMed ID: 10541271
[TBL] [Abstract][Full Text] [Related]
15. Osteocalcin gene Hind III polymorphism is not correlated with calcium oxalate stone disease.
Chen WC; Chen HY; Wu JY; Chen YT; Tsai FJ
Urol Res; 2001 Apr; 29(2):98-101. PubMed ID: 11396736
[TBL] [Abstract][Full Text] [Related]
16. TAP 2 gene Msp-I polymorphism might be associated with calcium oxalate stone disease.
Huang SH; Chen RH; Wan L; Tsai FJ; Chen WC
Urol Int; 2005; 75(3):264-8. PubMed ID: 16215317
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease.
Chen WC; Chen HY; Wu HC; Wu MC; Hsu CD; Tsai FJ
Urol Res; 2003 Jul; 31(3):218-22. PubMed ID: 12719950
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
J Neuroimmunol; 2003 Mar; 136(1-2):125-9. PubMed ID: 12620651
[TBL] [Abstract][Full Text] [Related]
19. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Mol Urol; 2000; 4(4):383-90. PubMed ID: 11156706
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones.
Chen WC; Wu HC; Lu HF; Chen HY; Tsai FJ
Eur Urol; 2001 Jun; 39(6):716-9. PubMed ID: 11464063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
